Subscribe
Search
News & Politics
Culture
Food
Science & Health
Money
Life Stories
Video
Reviews
Lifestyle
The New Sober Boom
Getting Hooked on Quitting
Education
Liberal Arts Cuts Are Dangerous
Is College Necessary?
Finance
Dying Parents Costing Millennials Dear
Gen Z Investing In Le Creuset
Crypto
Investing
SEC vs Celebrity Crypto Promoters
‘Dark’ Personalities Drawn to BTC
News & Politics
Culture
Food
Science & Health
Money
Life Stories
Video
Reviews
Lifestyle
The New Sober Boom
Getting Hooked on Quitting
Education
Liberal Arts Cuts Are Dangerous
Is College Necessary?
Finance
Dying Parents Costing Millennials Dear
Gen Z Investing In Le Creuset
Crypto
Investing
SEC vs Celebrity Crypto Promoters
‘Dark’ Personalities Drawn to BTC
Subscribe
Help keep Salon independent
Newsletter
News & Politics
Culture
Food
Science & Health
Money
Video
Search
Sarah Jane Tribble
Advertisement:
Can family doctors deliver rural America from its maternal health crisis?
Sarah Jane Tribble
It’s “telehealth vs. no care”: Doctors say Congress risks leaving patients vulnerable
Sarah Jane Tribble
Novavax missed its global moonshot but is angling to win over mRNA defectors
Arthur Allen, Sarah Jane Tribble
How Fauci and the NIH got ahead of the FDA and CDC in backing boosters
Sarah Jane Tribble, Arthur Allen
Rush to boosters sparks confusion, differing recommendations
Sarah Jane Tribble
Pfizer CEO to public: just trust us on the COVID booster
Sarah Jane Tribble
Trump adds a global pricing plan to wide attack on drug prices, but doubts persist
Sarah Jane Tribble
Unwitting patients, copycat comments play hidden role in federal rule-making
Sarah Jane Tribble
Déjà voodoo: Pharma’s promises to curb drug prices have been heard before
Jay Hancock, Sarah Jane Tribble
How a drugmaker turned the abortion pill into a rare-disease profit machine
Sarah Jane Tribble
FDA head vows to tackle high drug prices and drugmakers “gaming the system”
Sarah Jane Tribble, Liz Szabo
Trump’s budget proposal swings at drug prices with a glancing blow
Sarah Jane Tribble
FDA Chief open to rethinking incentives on orphan drugs
Sarah Jane Tribble
Experts tell Congress how to cut drug prices. We give you some odds
Sarah Jane Tribble
Will Medicare patients get a cut of prescription deals?
Sarah Jane Tribble
Drug rebates reward industry players — and often hurt patients
Sarah Jane Tribble
A major drug company left its lobbying group over a drug price controversy
Sarah Jane Tribble
Big pharma is “getting away with murder”: Drugmakers help turn patients with rare diseases into D.C. lobbyists
Sarah Jane Tribble
GAO to launch investigation of FDA’s Orphan Drug Program
Sarah Jane Tribble
This is an alert message.
OK